TrialClinical cancer research : an official journal of the American Association for Cancer Research2012

Thalidomide in total therapy 2 overcomes inferior prognosis of myeloma with low expression of the glucocorticoid receptor gene NR3C1.

Christoph J Heuck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.